The North America nasal spray market is estimated to register a CAGR of 9.23% during the forecast period, 2021-2028. As per the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), chronic obstructive pulmonary disease (COPD) has caused breathing problems in millions of Americans.

NORTH AMERICA NASAL SPRAY MARKET FORECAST 2021-2028

North America Nasal Spray Market by Product (Decongestion Nasal Spray, Steroid Nasal Spray, Saltwater Solution/saline Nasal Spray) Market by Prescription (Over the Counter, Prescribed) Market by Therapeutic (Antihistamine, Nasal Steroids, Anticholinergic, Mast Cell Inhibitor) Market by Application (Nasal Congestion, Allergic and Non-allergic Rhinitis, Vaccination, CNS Disorders, Other Applications) Market by End-user (Home Care Setting, ASC/clinics, Pharmacy, Hospital, Other End-users) by Geography.

Request free sample

The North America nasal spray market is estimated to register a CAGR of 9.23% during the forecast period, 2021-2028. As per the National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), chronic obstructive pulmonary disease (COPD) has caused breathing problems in millions of Americans.north-america-nasal-spray-market

To know more about this report, request a free sample copy.

The North America nasal spray market growth assessment includes the analysis of the United States and Canada. In the United States, as per the industry sources, almost 1 billion suffer from the common cold every year. Also, over 25 million have asthma, according to the US Department of Health and Human Services. The annual health care expenditure for asthma totals $20.7 billion. Further, over 16.4 million have COPD, which causes cough, breathing difficulty, wheezing, and mucus production.

Furthermore, lung disease is the third leading cause of death in the country. Around 37 million have a chronic lung disease like COPD or asthma, as per the American Lung Association. The US is also one of the biggest polluters globally. Air pollution leads to respiratory diseases like lung cancer, asthma, COPD, etc. Moreover, allergic rhinitis (AR) is the most prevalent chronic condition in the pediatric and adolescent population. It is also the most common atopic condition, affecting 10-30% of the adult population and 40% of children.

Pfizer is a research-based firm involved in the development, discovery, manufacture, and distribution of healthcare products. Its research and development expenditure substantially increased over recent years. With 43 production facilities globally, the company sells its products in over 125 nations. Pfizer is headquartered in the United States.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISING ADOPTION OF NASAL SPRAYS AMONG PATIENTS
        • GROWING ACCEPTANCE OF SELF-MEDICATION
        • INCREASING INTRANASAL VACCINES FOR COVID-19
      • KEY RESTRAINTS
        • OVERUSE RISKS ASSOCIATED WITH NASAL SPRAYS
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON NASAL SPRAY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PRODUCT
      • DECONGESTION NASAL SPRAY
      • STEROID NASAL SPRAY
      • SALTWATER SOLUTION/SALINE NASAL SPRAY
    3. MARKET BY PRESCRIPTION
      • OVER THE COUNTER
      • PRESCRIBED
    4. MARKET BY THERAPEUTIC
      • ANTIHISTAMINE
      • NASAL STEROIDS
      • ANTICHOLINERGIC
      • MAST CELL INHIBITOR
    5. MARKET BY APPLICATION
      • NASAL CONGESTION
      • ALLERGIC AND NON-ALLERGIC RHINITIS
      • VACCINATION
      • CNS DISORDERS
      • OTHER APPLICATIONS
    6. MARKET BY END-USER
      • HOME CARE SETTING
      • ASC/CLINICS
      • PHARMACY
      • HOSPITAL
      • OTHER END-USERS
    7. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY DRIVERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • AKORN INCORPORATED
        • ALLERGAN PLC
        • APOTEX INC
        • BHARAT BIOTECH
        • CATALENT INC
        • CIPLA LIMITED
        • GLAXOSMITHKLINE PLC
        • JOHNSON & JOHNSON
        • NOVARTIS INTERNATIONAL AG
        • PFIZER INC
        • PROCTOR & GAMBLE CO (P&G)
        • SANOTIZE RESEARCH AND DEVELOPMENT
        • SUN PHARMACEUTICALS INDUSTRIES LTD
        • TEVA PHARMACEUTICALS INDUSTRIES LTD
        • VIATRIS

    TABLE LIST

    TABLE 1: MARKET SNAPSHOT – NASAL SPRAY

    TABLE 2: NORTH AMERICA NASAL SPRAY MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: NORTH AMERICA NASAL SPRAY MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: NORTH AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: NORTH AMERICA NASAL SPRAY MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: NORTH AMERICA NASAL SPRAY MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: NORTH AMERICA NASAL SPRAY MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: NORTH AMERICA NASAL SPRAY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: KEY PLAYERS IN NORTH AMERICA NASAL SPRAY MARKET

    TABLE 15: LIST OF MERGERS & ACQUISITIONS

    TABLE 16: LIST OF PARTNERSHIPS & AGREEMENTS

    FIGURE LIST

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: NORTH AMERICA NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2020

    FIGURE 6: NORTH AMERICA NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

    FIGURE 7: NORTH AMERICA NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

    FIGURE 8: NORTH AMERICA NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

    FIGURE 9: NORTH AMERICA NASAL SPRAY MARKET, GROWTH POTENTIAL, BY PRESCRIPTION, IN 2020

    FIGURE 10: NORTH AMERICA NASAL SPRAY MARKET, BY OVER THE COUNTER, 2021-2028 (IN $ MILLION)

    FIGURE 11: NORTH AMERICA NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

    FIGURE 12: NORTH AMERICA NASAL SPRAY MARKET, GROWTH POTENTIAL, BY THERAPEUTIC, IN 2020

    FIGURE 13: NORTH AMERICA NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

    FIGURE 14: NORTH AMERICA NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

    FIGURE 15: NORTH AMERICA NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

    FIGURE 16: NORTH AMERICA NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

    FIGURE 17: NORTH AMERICA NASAL SPRAY MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

    FIGURE 18: NORTH AMERICA NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

    FIGURE 19: NORTH AMERICA NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

    FIGURE 20: NORTH AMERICA NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

    FIGURE 21: NORTH AMERICA NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

    FIGURE 22: NORTH AMERICA NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 23: NORTH AMERICA NASAL SPRAY MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

    FIGURE 24: NORTH AMERICA NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

    FIGURE 25: NORTH AMERICA NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

    FIGURE 26: NORTH AMERICA NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

    FIGURE 27: NORTH AMERICA NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

    FIGURE 28: NORTH AMERICA NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

    FIGURE 29: NORTH AMERICA NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 30: UNITED STATES NASAL MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 31: CANADA NASAL SPRAY MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • NORTH AMERICA
        • MARKET SIZE & ESTIMATES
        • KEY DRIVERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED STATES
          • CANADA
    1. MARKET BY PRODUCT
      • DECONGESTION NASAL SPRAY
      • STEROID NASAL SPRAY
      • SALTWATER SOLUTION/SALINE NASAL SPRAY
    2. MARKET BY PRESCRIPTION
      • OVER THE COUNTER
      • PRESCRIBED
    3. MARKET BY THERAPEUTIC
      • ANTIHISTAMINE
      • NASAL STEROIDS
      • ANTICHOLINERGIC
      • MAST CELL INHIBITOR
    4. MARKET BY APPLICATION
      • NASAL CONGESTION
      • ALLERGIC AND NON-ALLERGIC RHINITIS
      • VACCINATION
      • CNS DISORDERS
      • OTHER APPLICATIONS
    5. MARKET BY END-USER
      • HOME CARE SETTING
      • ASC/CLINICS
      • PHARMACY
      • HOSPITAL
      • OTHER END-USERS

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type